miR-3191 and its role in liver cancer
Author Information
Author(s): Xie Anqi, Wang Hengjie, Huang Jingchen, Sun Minmin, Chen Lin
Primary Institution: Community Health Service Center, Zhongshan Street, Songjiang District, Shanghai, China
Hypothesis
miR-3191 promotes the proliferation and metastasis of hepatocellular carcinoma via regulating PAK6.
Conclusion
miR-3191 promotes the proliferation and metastasis of HCC cells via targeting PAK6 and may serve as a prognostic biomarker and potential therapeutic target.
Supporting Evidence
- miR-3191 expression was significantly increased in HCC tissues compared with paired non-cancerous tissues.
- High miR-3191 expression was associated with aggressive clinical features and poor overall survival in HCC patients.
- Knockdown of miR-3191 inhibited HCC cell proliferation and metastasis in vitro and in vivo.
Takeaway
This study found that a tiny molecule called miR-3191 helps liver cancer cells grow and spread by affecting another protein called PAK6.
Methodology
The study used quantitative real-time PCR, cell proliferation assays, and animal models to investigate the role of miR-3191 in HCC.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully replicate human disease complexity.
Participant Demographics
Patients with hepatocellular carcinoma who underwent surgical resection.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website